Why Investors Need to Take Advantage of These 2 Computer and Technology Stocks Now
Source: zacks.com
Zacks flagged Micron and Alphabet as potential earnings-beat candidates based on positive Earnings ESP readings ahead of their next reports. Micron, rated Zacks Rank #2 (Buy), has a most-accurate EPS estimate of $31.71 versus $31.45 consensus, implying a +0.81% ESP for its September 30, 2026 release. Alphabet, rated #3 (Hold), has a $3.03 estimate versus $2.93 consensus, or a +3.41% ESP, ahead of its November 4, 2026 earnings report.
Analysis
This is a weak standalone signal rather than new fundamental information. Small dispersion between a recent estimate and consensus is often driven by model timing, buyback assumptions, or one analyst's update; it does not establish that either MU or GOOG has an information advantage. The key earnings-trade variable is not beat probability but the gap between implied move, positioning, and the forward guidance revision required to sustain a rerating.
For MU, the relevant read-through is memory pricing and high-bandwidth-memory mix: a reported beat without upward commentary on DRAM/NAND contract pricing, HBM qualification volumes, and gross-margin exit rate is vulnerable to a sell-the-news reaction. A stronger MU print would modestly reinforce demand expectations for memory-equipment suppliers such as LRCX, KLAC and AMAT over the next 1-3 months, but could also revive concerns that capex response eventually caps the upcycle in 6-18 months.
For GOOG, an EPS beat is lower quality if it comes from expense timing, tax, or buybacks rather than incremental Search monetization and cloud profitability. The more consequential catalyst is evidence that AI-related capex is producing revenue and defending query share; failure to show that linkage would pressure the multiple even with an accounting beat. Consensus likely overweights the binary beat/miss framing and underweights forward capex intensity, which determines whether AI investment is margin-accretive or a drag.
No directional position is warranted solely on this research-provider screen. Falsification for a constructive MU view is a weaker next-quarter gross-margin guide or evidence of inventory rebuilding; for GOOG it is decelerating Search/Cloud growth alongside another material increase in capex guidance.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.32
Ticker Sentiment
Key Decisions for Investors
- MU: maintain only a watch-list bias into the September 30 report; consider a 1-2 month long only if channel checks confirm rising DRAM/HBM pricing and implied volatility is below the stock's realized earnings move. Exit on gross-margin guidance below expectations, regardless of the headline EPS result.
- Use a relative-value expression rather than an outright pre-earnings bet: long MU / short SOXX in modest size after a post-report pullback if management raises memory pricing or HBM mix assumptions. This isolates company-specific operating leverage; close if MU underperforms SOXX by 8-10% after guidance.
- GOOG: wait for evidence on Search monetization and Cloud operating margin before adding exposure ahead of the November report. If implied volatility rises materially into earnings without corresponding estimate revisions, a defined-risk post-earnings call spread is preferable to pre-event directional stock exposure.
- Monitor LRCX, KLAC and AMAT for a secondary MU catalyst: add selectively only if MU's guidance implies durable capacity additions rather than pricing-led growth. A capex-light memory recovery benefits MU cash flow but offers limited incremental orders for equipment vendors.
More News
- Google's Gemini becomes latest AI model to break out and hack computer systems
- Google’s Gemini AI hacks 3 companies in security test, then stops
- Exclusive-Anthropic considers releasing new AI model ahead of IPO, sources say
- Google says its Gemini AI model hacked three other companies
- Traders Wary Of Rising AI Risks: Market Snapshot
- Anthropic quietly sets up biology lab as it ramps AI drug program: Reuters